In the mental health field, we tend to pathologize and diagnose even commonly encountered challenges. Through the lens of human experience, however, we can recognize that some emotional and mental ...

Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point where they rarely leave their home and are unable to work and build meaningful ...

Generalized anxiety disorder affects millions, often trapping sufferers in cycles of fear and isolation that conventional medications barely relieve. At UCSF, neuroscientist Jennifer Mitchell is ...

Cybin Inc (NASDAQ:HELP) is among the best psychedelic stocks to buy in 2026. Toronto, Canada-based Cybin Inc. is also known ...

What few people, regardless of their politics, ever think to ask is: What is a “mental disorder”? The Diagnostic and Statistical Manual of Mental Disorders (DSM), “the bible” of the American ...

A new research study showcases compelling evidence for AI-based mental health apps. Limitations exist. An AI Insider scoop.

Please provide your email address to receive an email when new articles are posted on . NEW YORK — One dose of lysergide produced clinical remission of generalized anxiety disorder as soon as 4 weeks ...

Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Effexor® SR 37.5 mg / 75 mg capsules (venlafaxine ...

Add Yahoo as a preferred source to see more of our stories on Google. TUPELO – Anxiety is a normal response to a stressor, something that causes strain or tension. By itself, anxiety shouldn’t be made ...

Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point they rarely leave their home and are unable to work and build meaningful ...